Paper42903311PubMed
Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer.
Yu SY and 8 others. Front Microbiol, 2026.
Cite this record
ConductScience Library. Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer. Papers, record 42903311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903311
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer.
- Journal
- Front Microbiol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-23
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24388214 | The role of short-chain fatty acids in health and disease. | Adv Immunol | 2014 | https://conductscience.org/library/papers/24388214 | PubMed |
| 2 | 25956767 | Energy Conservation Model Based on Genomic and Experimental Analyses of a Carbon Monoxide-Utilizing, Butyrate-Forming Acetogen, Eubacterium limosum KIST612. | Appl Environ Microbiol | 2015 | https://conductscience.org/library/papers/25956767 | PubMed |
| 3 | 33652061 | Gut microbes and health. | Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33652061 | PubMed |
| 4 | 20383131 | QIIME allows analysis of high-throughput community sequencing data. | Nat Methods | 2010 | https://conductscience.org/library/papers/20383131 | PubMed |
| 5 | 32457487 | Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. | Cancer Gene Ther | 2021 | https://conductscience.org/library/papers/32457487 | PubMed |
| 6 | 36189423 | Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/36189423 | PubMed |
| 7 | 35736458 | An Improved Method to Quantify Short-Chain Fatty Acids in Biological Samples Using Gas Chromatography-Mass Spectrometry. | Metabolites | 2022 | https://conductscience.org/library/papers/35736458 | PubMed |
| 8 | 36564565 | Tumour-infiltrating lymphocytes: from prognosis to treatment selection. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36564565 | PubMed |
| 9 | 33549042 | Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33549042 | PubMed |
| 10 | 26210164 | Proteobacteria: microbial signature of dysbiosis in gut microbiota. | Trends Biotechnol | 2015 | https://conductscience.org/library/papers/26210164 | PubMed |
| 11 | 36440358 | Next-Generation Probiotics: Microflora Intervention to Human Diseases. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36440358 | PubMed |
| 12 | 32433595 | Interaction between microbiota and immunity in health and disease. | Cell Res | 2020 | https://conductscience.org/library/papers/32433595 | PubMed |
| 13 | 34867852 | Cell-Free Supernatant of Odoribacter splanchnicus Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34867852 | PubMed |
| 14 | 36448791 | Gut Microbiota Eubacterium callanderi Exerts Anti-Colorectal Cancer Activity. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/36448791 | PubMed |
| 15 | 30214578 | Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK-κB in colon cancer cell in vitro. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30214578 | PubMed |
| 16 | 31281534 | Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. | Theranostics | 2019 | https://conductscience.org/library/papers/31281534 | PubMed |
| 17 | 34210970 | Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/34210970 | PubMed |
| 18 | 40568973 | Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer. | ISME J | 2025 | https://conductscience.org/library/papers/40568973 | PubMed |
| 19 | 25392425 | Rfam 12.0: updates to the RNA families database. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25392425 | PubMed |
| 20 | 34895176 | Gut microbiome and its role in colorectal cancer. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34895176 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42903311
GET https://conductscience.org/api/papers/v1/42903311/references?page=2